News - Page 90 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Silo Pharma Announces Closing of $5.75 Million Public Offering of Common Stock, Nasdaq Listing, and Full Exercise of Underwriter’s Over-Allotment Option

Silo Pharma Announces Closing of $5.75 Million Public Offering of Common Stock, Nasdaq Listing, and Full Exercise of Underwriter’s Over-Allotment Option

Post published:October 1, 2022
Post category:Press Release

Read more about the article Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting

Reunion Neuroscience Inc. Announces Results of Annual General and Special Shareholder Meeting

Post published:September 30, 2022
Post category:Press Release

Read more about the article Psyence Group Completes Export of Psilocybin Mushrooms to Portugal

Psyence Group Completes Export of Psilocybin Mushrooms to Portugal

Post published:September 30, 2022
Post category:Press Release

Read more about the article Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022

Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022

Post published:September 30, 2022
Post category:Press Release

Read more about the article Psychedelic Bulletin #119: More Misery for MindMed; Another Psychedelics Co. Ceases Operations; A Brief Dispatch from ICPR

Psychedelic Bulletin #119: More Misery for MindMed; Another Psychedelics Co. Ceases Operations; A Brief Dispatch from ICPR

Post published:September 30, 2022
Post category:Psychedelic Bulletin

Read more about the article PharmaTher Provides Business Highlights and Releases Audited Annual Financials for Fiscal Year Ended May 31, 2022

PharmaTher Provides Business Highlights and Releases Audited Annual Financials for Fiscal Year Ended May 31, 2022

Post published:September 29, 2022
Post category:Press Release

Read more about the article Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer

Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive Officer

Post published:September 28, 2022
Post category:Press Release

Read more about the article MindMed Announces Pricing of Public Offering of Common Shares and Warrants

MindMed Announces Pricing of Public Offering of Common Shares and Warrants

Post published:September 28, 2022
Post category:Press Release

Read more about the article Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Post published:September 28, 2022
Post category:Press Release

Read more about the article Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock

Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock

Post published:September 28, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.